[1]
Carneiro C, Brito J, Bilreiro C, Barros M, Bahia C, Santiago I, Caseiro-Alves F. All about portal vein: a pictorial display to anatomy, variants and physiopathology. Insights into imaging. 2019 Mar 21:10(1):38. doi: 10.1186/s13244-019-0716-8. Epub 2019 Mar 21
[PubMed PMID: 30900187]
Level 3 (low-level) evidence
[2]
Sakiani S, Heller T, Koh C. Current and investigational drugs in early clinical development for portal hypertension. Frontiers in medicine. 2022:9():974182. doi: 10.3389/fmed.2022.974182. Epub 2022 Oct 10
[PubMed PMID: 36300180]
[3]
Granger DN, Holm L, Kvietys P. The Gastrointestinal Circulation: Physiology and Pathophysiology. Comprehensive Physiology. 2015 Jul 1:5(3):1541-83. doi: 10.1002/cphy.c150007. Epub
[PubMed PMID: 26140727]
[4]
Salembier A, Verhamme M, Verhamme P, Van Moerkercke W. Acute non-cirrhotic portal vein thrombosis : review. Acta gastro-enterologica Belgica. 2018 Apr-Jun:81(2):318-322
[PubMed PMID: 30024704]
[5]
Denninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (Baltimore, Md.). 2000 Mar:31(3):587-91
[PubMed PMID: 10706547]
[6]
Chawla YK, Bodh V. Portal vein thrombosis. Journal of clinical and experimental hepatology. 2015 Mar:5(1):22-40. doi: 10.1016/j.jceh.2014.12.008. Epub 2015 Jan 6
[PubMed PMID: 25941431]
[7]
Naymagon L, Tremblay D, Mascarenhas J, Schiano T. Characteristics, anticoagulation, and outcomes of portal vein thrombosis after intra-abdominal surgery. Surgery. 2021 May:169(5):1175-1181. doi: 10.1016/j.surg.2020.11.016. Epub 2020 Dec 24
[PubMed PMID: 33358635]
[8]
Shoar S, Saber AA, Rubenstein R, Safari S, Brethauer SA, Al-Thani H, Asarian AP, Aminian A. Portomesentric and splenic vein thrombosis (PMSVT) after bariatric surgery: a systematic review of 110 patients. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2018 Jan:14(1):47-59. doi: 10.1016/j.soard.2017.09.512. Epub 2017 Sep 14
[PubMed PMID: 29111221]
Level 1 (high-level) evidence
[9]
Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C, Prisco D. Vascular Behçet's syndrome: an update. Internal and emergency medicine. 2019 Aug:14(5):645-652. doi: 10.1007/s11739-018-1991-y. Epub 2018 Nov 29
[PubMed PMID: 30499073]
[10]
Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology. 2019 May:156(6):1582-1599.e1. doi: 10.1053/j.gastro.2019.01.265. Epub 2019 Feb 13
[PubMed PMID: 30771355]
[11]
Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kitami N, Sato N, Abe H, Aoki Y, Hoshi T, Hashimoto H. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver. 2000 Oct:20(5):366-73
[PubMed PMID: 11092254]
Level 3 (low-level) evidence
[12]
Rabie H, Othman W, Elsabaawy DM, Elshemy EE, Abdelmageed N, Khalaf FA, Bedair HM. Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma. Asian Pacific journal of cancer prevention : APJCP. 2021 Jan 1:22(1):267-275. doi: 10.31557/APJCP.2021.22.1.267. Epub 2021 Jan 1
[PubMed PMID: 33507708]
[13]
Gattini D, Cifuentes LI, Torres-Robles R, Gana JC. Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. The Cochrane database of systematic reviews. 2020 Jan 10:1(1):CD011659. doi: 10.1002/14651858.CD011659.pub2. Epub 2020 Jan 10
[PubMed PMID: 31922266]
Level 1 (high-level) evidence
[14]
Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Naymagon S, Mascarenhas J, Schiano T. The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases. 2021 Jan 19:27(2):215-223. doi: 10.1093/ibd/izaa053. Epub
[PubMed PMID: 32185400]
[15]
Ma SD, Wang J, Bezinover D, Kadry Z, Northup PG, Stine JG. Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta-analysis. Research and practice in thrombosis and haemostasis. 2019 Oct:3(4):658-667. doi: 10.1002/rth2.12253. Epub 2019 Sep 10
[PubMed PMID: 31624785]
Level 1 (high-level) evidence
[16]
How J, Zhou A, Oh ST. Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease. Therapeutic advances in hematology. 2017 Mar:8(3):107-118. doi: 10.1177/2040620716680333. Epub 2016 Dec 8
[PubMed PMID: 28246554]
Level 3 (low-level) evidence
[17]
Kashirin SD, Kozhevnikov VA, Suvorova AV, Khaziev AT, Golovko VI. [A differentiated approach to the diagnosis and treatment of portal hypertension in children]. Vestnik khirurgii imeni I. I. Grekova. 2011:170(5):44-8
[PubMed PMID: 22238965]
[18]
Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R, Gasbarrini A. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World journal of gastroenterology. 2010 Jan 14:16(2):143-55
[PubMed PMID: 20066733]
[19]
Boucher AA, Wastvedt S, Hodges JS, Beilman GJ, Kirchner VA, Pruett TL, Hering BJ, Schwarzenberg SJ, Downs E, Freeman M, Trikudanathan G, Chinnakotla S, Bellin MD. Portal Vein Thrombosis May Be More Strongly Associated With Islet Infusion Than Extreme Thrombocytosis After Total Pancreatectomy With Islet Autotransplantation. Transplantation. 2021 Nov 1:105(11):2499-2506. doi: 10.1097/TP.0000000000003624. Epub
[PubMed PMID: 33988346]
[20]
Nawacki Ł, Matykiewicz J, Stochmal E, Głuszek S. Splanchnic Vein Thrombosis in Acute Pancreatitis and Its Consequences. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2021 Jan-Dec:27():10760296211010260. doi: 10.1177/10760296211010260. Epub
[PubMed PMID: 33887991]
[21]
Wang R, Guo X, Tang Y, Qi X. Portal vein thrombosis as the first presentation of paroxysmal nocturnal hemoglobinuria. Drug discoveries & therapeutics. 2022 Sep 17:16(4):200-203. doi: 10.5582/ddt.2022.01033. Epub 2022 Aug 21
[PubMed PMID: 35989282]
Level 2 (mid-level) evidence
[22]
Jabiry-Zieniewicz Z, Dabrowski FA, Suchońska B, Kowalczyk R, Nowacka E, Kociszewska-Najman B, Pietrzak B, Malkowski P, Wielgos M. Pregnancy and delivery in women with esophageal varices due to hepatic vein thrombosis. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2015 Jan:28(2):177-81. doi: 10.3109/14767058.2014.908846. Epub 2014 Apr 29
[PubMed PMID: 24670239]
[23]
van Vroonhoven TJ, Molenaar JC. Distal splenorenal shunt for decompression of portal hypertension in children with cystic fibrosis. Surgery, gynecology & obstetrics. 1979 Oct:149(4):559-60
[PubMed PMID: 483134]
[24]
Lv Y, Bai W, Li K, Wang Z, Guo W, Luo B, Wang J, Wang Q, Wang E, Xia D, Li X, Yuan J, Han N, Niu J, Yin Z, Fan D, Han G. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study. The American journal of gastroenterology. 2021 Jul 1:116(7):1447-1464. doi: 10.14309/ajg.0000000000001194. Epub
[PubMed PMID: 33630766]
Level 2 (mid-level) evidence
[25]
Buzelé R, Barbier L, Sauvanet A, Fantin B. Medical complications following splenectomy. Journal of visceral surgery. 2016 Aug:153(4):277-86. doi: 10.1016/j.jviscsurg.2016.04.013. Epub 2016 Jun 8
[PubMed PMID: 27289254]
[26]
Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges. Annals of gastroenterology. 2018 May-Jun:31(3):315-329. doi: 10.20524/aog.2018.0245. Epub 2018 Mar 3
[PubMed PMID: 29720857]
[27]
Pan J, Wang L, Gao F, An Y, Yin Y, Guo X, Nery FG, Yoshida EM, Qi X. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. European journal of internal medicine. 2022 Oct:104():21-32. doi: 10.1016/j.ejim.2022.05.032. Epub 2022 Jun 7
[PubMed PMID: 35688747]
Level 1 (high-level) evidence
[28]
Odriozola A, Puente Á, Cuadrado A, Rivas C, Anton Á, González FJ, Pellón R, Fábrega E, Crespo J, Fortea JI. Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review. Journal of clinical medicine. 2022 Oct 30:11(21):. doi: 10.3390/jcm11216435. Epub 2022 Oct 30
[PubMed PMID: 36362663]
[29]
Xu X, Guo X, De Stefano V, Silva-Junior G, Goyal H, Bai Z, Zhao Q, Qi X. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. Hepatology international. 2019 Jul:13(4):468-481. doi: 10.1007/s12072-019-09951-6. Epub 2019 Jun 7
[PubMed PMID: 31175581]
Level 1 (high-level) evidence
[30]
Liu PH, Huo TI, Miksad RA. Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies. Seminars in liver disease. 2018 Aug:38(3):242-251. doi: 10.1055/s-0038-1666805. Epub 2018 Jul 24
[PubMed PMID: 30041276]
[31]
Qi X, Ren W, De Stefano V, Fan D. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2014 Nov:12(11):1801-12.e7. doi: 10.1016/j.cgh.2014.04.026. Epub 2014 Apr 30
[PubMed PMID: 24793031]
Level 1 (high-level) evidence
[32]
Zhang P, Zhang J, Sun G, Gao X, Wang H, Yan W, Xu H, Zu M, Ma H, Wang W, Lu Z. Risk of Budd-Chiari syndrome associated with factor V Leiden and G20210A prothrombin mutation: a meta-analysis. PloS one. 2014:9(4):e95719. doi: 10.1371/journal.pone.0095719. Epub 2014 Apr 22
[PubMed PMID: 24755609]
Level 1 (high-level) evidence
[33]
Fasola FA, Akere A, Akunwata CU, Onyejelam C, Osundina MA. Protein C Deficiency in a Patient with Anomalous Hemiazygous Vein and Portal Vein Thrombosis. West African journal of medicine. 2021 Apr 23:38(4):387-390
[PubMed PMID: 33903797]
[34]
Hung HC, Lee JC, Cheng CH, Wang YC, Wu TH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC. Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation. Journal of clinical medicine. 2020 Apr 20:9(4):. doi: 10.3390/jcm9041181. Epub 2020 Apr 20
[PubMed PMID: 32326024]
[35]
Setaka T, Hirano K, Moriya K, Kaneko T, Morita S, Shinkai T, Morishita E, Ichida T. Portal Vein Thrombosis in a Patient with Hereditary Antithrombin Deficiency. Internal medicine (Tokyo, Japan). 2019 Jun 15:58(12):1733-1737. doi: 10.2169/internalmedicine.2295-18. Epub 2019 Feb 25
[PubMed PMID: 30799362]
[36]
Ghumman GM, Ishtiaq R, Avasthi D. Portal Vein Thrombosis in a Patient With Methylenetetrahydrofolate Reductase Gene Mutation and Normal Homocysteine Levels. Cureus. 2021 Sep:13(9):e18225. doi: 10.7759/cureus.18225. Epub 2021 Sep 23
[PubMed PMID: 34722031]
[37]
Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P, Denninger MH, Vidaud D, Condat B, Hadengue A, Primignani M, Garcia-Pagan JC, Janssen HL, Valla D, European Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology (Baltimore, Md.). 2010 Jan:51(1):210-8. doi: 10.1002/hep.23259. Epub
[PubMed PMID: 19821530]
[38]
Lin J, Zhou KR, Chen ZW, Wang JH, Wu ZQ, Fan J. Three-dimensional contrast-enhanced MR angiography in diagnosis of portal vein involvement by hepatic tumors. World journal of gastroenterology. 2003 May:9(5):1114-8
[PubMed PMID: 12717869]
[39]
Wolter K, Decker G, Kuetting D, Trebicka J, Manekeller S, Meyer C, Schild H, Thomas D. Interventional Treatment of Acute Portal Vein Thrombosis. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2018 Aug:190(8):740-746. doi: 10.1055/a-0631-9265. Epub 2018 Jul 25
[PubMed PMID: 30045398]
[40]
Rosenqvist K, Ebeling Barbier C, Rorsman F, Sangfelt P, Nyman R. Treatment of acute portomesenteric venous thrombosis with thrombectomy through a transjugular intrahepatic portosystemic shunt: a single-center experience. Acta radiologica (Stockholm, Sweden : 1987). 2018 Aug:59(8):953-958. doi: 10.1177/0284185117742683. Epub 2017 Dec 3
[PubMed PMID: 29202584]
[41]
Senzolo M, Garcia-Tsao G, García-Pagán JC. Current knowledge and management of portal vein thrombosis in cirrhosis. Journal of hepatology. 2021 Aug:75(2):442-453. doi: 10.1016/j.jhep.2021.04.029. Epub 2021 Apr 27
[PubMed PMID: 33930474]
[42]
Harding DJ, Perera MT, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World journal of gastroenterology. 2015 Jun 14:21(22):6769-84. doi: 10.3748/wjg.v21.i22.6769. Epub
[PubMed PMID: 26078553]
[43]
Weinberg EM, Palecki J, Reddy KR. Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis. Seminars in liver disease. 2019 May:39(2):195-208. doi: 10.1055/s-0039-1679934. Epub 2019 Apr 12
[PubMed PMID: 30978730]
[44]
García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP reports : innovation in hepatology. 2020 Aug:2(4):100122. doi: 10.1016/j.jhepr.2020.100122. Epub 2020 May 23
[PubMed PMID: 32671331]
[45]
Levi Sandri GB, Lai Q, Berloco PB, Rossi M. Portal vein thrombosis before liver transplant does not alter postoperative patient or graft survival. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 2014 Jun:12(3):238-40
[PubMed PMID: 24907725]
[46]
Potze W, Adelmeijer J, Porte RJ, Lisman T. Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis. Thrombosis research. 2015 May:135(5):1012-6. doi: 10.1016/j.thromres.2015.02.025. Epub 2015 Feb 26
[PubMed PMID: 25746364]
[47]
Intagliata NM, Henry ZH, Maitland H, Shah NL, Argo CK, Northup PG, Caldwell SH. Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation. Digestive diseases and sciences. 2016 Jun:61(6):1721-7. doi: 10.1007/s10620-015-4012-2. Epub 2016 Jan 2
[PubMed PMID: 26725062]
[48]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Vascular diseases of the liver. Journal of hepatology. 2016 Jan:64(1):179-202. doi: 10.1016/j.jhep.2015.07.040. Epub 2015 Oct 26
[PubMed PMID: 26516032]
Level 1 (high-level) evidence
[49]
Gameiro AF, Robalo Nunes A, Guerra P, Mateus E, Fernandes F. Portal Vein Thrombosis Secondary to Occult Polycythemia Vera. European journal of case reports in internal medicine. 2020:7(12):002003. doi: 10.12890/2020_002003. Epub 2020 Nov 2
[PubMed PMID: 33457359]
Level 3 (low-level) evidence
[50]
Loffredo L, Pastori D, Farcomeni A, Violi F. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis. Gastroenterology. 2017 Aug:153(2):480-487.e1. doi: 10.1053/j.gastro.2017.04.042. Epub 2017 May 4
[PubMed PMID: 28479379]
Level 1 (high-level) evidence
[51]
Gebreselassie A, Bukhari M, Awan A, Khashab M. Recurrent Biliary Obstruction Secondary to Portal Biliopathy and the Role of Cholangioscopy: A Case Report [corrected]. Cureus. 2018 Jan 9:10(1):e2046. doi: 10.7759/cureus.2046. Epub 2018 Jan 9
[PubMed PMID: 29541567]
Level 3 (low-level) evidence